Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BAXTER INTERNATIONAL INCBAX · Entity 1707 | Director | May 06, 2025 | May 08, 2025 |
| BOSTON SCIENTIFIC CORPBSX · Entity 1897 | Director | May 07, 2026 | May 11, 2026 |
| NeueHealth, Inc.BHG · Entity 74308 | CFO & CAO | March 13, 2023 | March 16, 2023 |
| PPG INDUSTRIES INCPPG · Entity 3193 | Director | April 15, 2026 | April 17, 2026 |
| STARBUCKS CORPSBUX · Entity 2886 | evp, cfo | March 24, 2026 | March 26, 2026 |
| TARGET CORPTGT · Entity 2967 | Executive Officer | August 23, 2019 | August 26, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BAXTER INTERNATIONAL INC
Report date May 06, 2025 · Filed May 08, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $1 par valueSEC Table I · non-derivative | Direct | 30,345 |
Reported balance
After 2025-05-06 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-05-06 · Grant · Acquired 7,183 · Balance 30,345 F1: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. F2: Total includes the automatic reinvestment of dividends. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.
F2: Total includes the automatic reinvestment of dividends.
BOSTON SCIENTIFIC CORP
Report date May 07, 2026 · Filed May 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 4,679 |
Reported balance
After 2026-05-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-07 · Grant · Acquired 3,800 · Balance 4,679 F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F2: Reflects a value of $215,000 divided by the closing price of common stock on the date of grant. F3: Annual equity award in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Director service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 6,888 |
Reported balance
After 2026-05-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-07 · Grant · Acquired 2,209 · Balance 6,888 F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F4: Deferred stock units were granted in lieu of 100% yearly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $125,000 (representing 100% of the amount of the non-employee director compensation program's cash retainer) divided by the closing price of the common stock on the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2: Reflects a value of $215,000 divided by the closing price of common stock on the date of grant.
F3: Annual equity award in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Director service in accordance with the Company's Non-Employee Director Deferred Compensation Plan.
F4: Deferred stock units were granted in lieu of 100% yearly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $125,000 (representing 100% of the amount of the non-employee director compensation program's cash retainer) divided by the closing price of the common stock on the date of grant.
NeueHealth, Inc.
Report date March 13, 2023 · Filed March 16, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 289,157 |
Reported balance
After 2023-03-13 transaction · row 1
1 source rowRow 1 · 2023-03-13 · Sale · Disposed 114,173 · Balance 289,157 F1: These shares were sold by the reporting person to cover tax withholding obligations upon the vesting of restricted stock units and were not discretionary transactions by the reporting person. F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.38 to $0.41 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were sold by the reporting person to cover tax withholding obligations upon the vesting of restricted stock units and were not discretionary transactions by the reporting person.
F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.38 to $0.41 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
PPG INDUSTRIES INC
Report date April 15, 2026 · Filed April 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,495 |
Ending reported balance
After 2026-04-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-04-15 · Exercise / conversion · Acquired 1,849 · Balance 9,501 F1: Upon the vesting of restricted stock units on April 15, 2026, which were granted to the reporting person on April 17, 2025, the reporting person is reporting the acquisition of 1,849 shares of common stock. Row 2 · 2026-04-15 · Tax withholding · Disposed 6 · Balance 9,495 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-04-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-04-15 · Exercise / conversion · Disposed 1,849 · Balance 0 F1: Upon the vesting of restricted stock units on April 15, 2026, which were granted to the reporting person on April 17, 2025, the reporting person is reporting the acquisition of 1,849 shares of common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,684 |
Reported balance
After 2026-04-16 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-04-16 · Grant · Acquired 1,684 · Balance 1,684 F2: Each restricted stock unit represents a contingent right to receive one share of PPG common stock. F3: The restricted stock units vest on April 14, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Upon the vesting of restricted stock units on April 15, 2026, which were granted to the reporting person on April 17, 2025, the reporting person is reporting the acquisition of 1,849 shares of common stock.
F2: Each restricted stock unit represents a contingent right to receive one share of PPG common stock.
F3: The restricted stock units vest on April 14, 2027.
STARBUCKS CORP
Report date March 24, 2026 · Filed March 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 63,751.726 |
Reported balance
After 2026-03-24 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-03-24 · Tax withholding · Disposed 2,231.435 · Balance 63,751.726 F1: Shares withheld by the issuer to satisfy tax withholding obligations upon vesting of restricted stock units; not an open market transaction. F2: Includes 860.423 shares representing dividend equivalents on unvested time-based restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld by the issuer to satisfy tax withholding obligations upon vesting of restricted stock units; not an open market transaction.
F2: Includes 860.423 shares representing dividend equivalents on unvested time-based restricted stock units.
TARGET CORP
Report date August 23, 2019 · Filed August 26, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,645 |
Reported balance
After 2019-08-23 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2019-08-23 · Sale · Disposed 8,412 · Balance 23,645 F1: Price is the volume weighted average selling price of all sales by the reporting person on the transaction date within a one dollar range. Actual prices ranged from $104.3981 to $104.4110. The reporting person hereby undertakes to provide upon request of the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2: Includes dividend equivalents paid on performance-based restricted stock units since the date of the reporting person's last filing through the date of the reported transaction that have been reinvested in additional performance-based restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Price is the volume weighted average selling price of all sales by the reporting person on the transaction date within a one dollar range. Actual prices ranged from $104.3981 to $104.4110. The reporting person hereby undertakes to provide upon request of the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2: Includes dividend equivalents paid on performance-based restricted stock units since the date of the reporting person's last filing through the date of the reported transaction that have been reinvested in additional performance-based restricted stock units.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
NORDSTROM INC
Report date March 21, 2025 · Filed March 24, 2025
Section 16 reporting ended · disclosed 2025-03-24. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 06, 2021 Filed Jul 1, 2021 01:45 UTC | NeueHealth, Inc. BHG · Entity 74308 | Exercise / conversionCommon Stock | 53,124 | $1.77 | $94,188.85 |
DisclosureSEC source: 0001415889-21-003299 · form4-06302021_090602.xml · nonDerivative · entry 13 Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,998 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2021 Filed May 6, 2021 22:02 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 2,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001322028-21-000001 · edgar.xml · nonDerivative · entry 1 Smith Cathy R · CIK 0001322028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,475 F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. Read SEC document |
| April 21, 2021 Filed Jul 1, 2021 01:45 UTC | NeueHealth, Inc. BHG · Entity 74308 | Exercise / conversionStock Options (Right to Buy) · Derivative | 12,501 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001415889-21-003299 · form4-06302021_090602.xml · derivative · entry 23 Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,001 Underlying: Common Stock · 12,501 shares Expires 2030-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These stock options vest over four years as follows: (a) 25% vested on February 19, 2021, and (b) 1/48 of the original grant amount (600,000) vests in monthly installments for the following three years. Read SEC document |
| April 21, 2021 Filed Jul 1, 2021 01:45 UTC | NeueHealth, Inc. BHG · Entity 74308 | Exercise / conversionCommon Stock | 12,501 | $1.77 | $22,164.27 |
DisclosureSEC source: 0001415889-21-003299 · form4-06302021_090602.xml · nonDerivative · entry 12 Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,874 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2021 Filed Apr 19, 2021 19:15 UTC | PPG INDUSTRIES INC PPG · Entity 3193 | GrantRestricted Stock Units · Derivative | 947 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-027244 · doc4.xml · derivative · entry 1 Smith Cathy R · CIK 0001322028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 947 Underlying: Common Stock · 947 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PPG Common Stock. F2 · derivative.exercise_date: The restricted stock units vest on April 20, 2022. F2 · derivative.expiration_date: The restricted stock units vest on April 20, 2022. Read SEC document |
| April 14, 2021 Filed Apr 17, 2021 00:01 UTC | PPG INDUSTRIES INC PPG · Entity 3193 | Exercise / conversionRestricted Stock Units · Derivative | 1,636 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-027070 · doc4.xml · derivative · entry 2 Smith Cathy R · CIK 0001322028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,636 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Upon the vesting of restricted stock units on April 14, 2021, which were granted to the reporting person on April 15, 2020, the reporting person is reporting the acquisition of 1,636 shares of common stock. F1 · derivative.exercise_date: Upon the vesting of restricted stock units on April 14, 2021, which were granted to the reporting person on April 15, 2020, the reporting person is reporting the acquisition of 1,636 shares of common stock. F1 · derivative.expiration_date: Upon the vesting of restricted stock units on April 14, 2021, which were granted to the reporting person on April 15, 2020, the reporting person is reporting the acquisition of 1,636 shares of common stock. Read SEC document |
| April 14, 2021 Filed Apr 17, 2021 00:01 UTC | PPG INDUSTRIES INC PPG · Entity 3193 | Exercise / conversionCommon Stock | 1,636 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-027070 · doc4.xml · nonDerivative · entry 1 Smith Cathy R · CIK 0001322028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,939 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Upon the vesting of restricted stock units on April 14, 2021, which were granted to the reporting person on April 15, 2020, the reporting person is reporting the acquisition of 1,636 shares of common stock. Read SEC document |
| April 06, 2021 Filed Jul 1, 2021 01:45 UTC | NeueHealth, Inc. BHG · Entity 74308 | Exercise / conversionStock Options (Right to Buy) · Derivative | 53,127 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001415889-21-003299 · form4-06302021_090602.xml · derivative · entry 22 Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,753,125 Underlying: Common Stock · 53,127 shares Expires 2029-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These stock options vest over four years as follows: (a) 25% vested on January 6, 2021, and (b) 1/48 of the original grant amount (2,550,000) vests in monthly installments for the following three years. Read SEC document |
| April 06, 2021 Filed Jul 1, 2021 01:45 UTC | NeueHealth, Inc. BHG · Entity 74308 | Exercise / conversionCommon Stock | 53,127 | $1.77 | $94,194.17 |
DisclosureSEC source: 0001415889-21-003299 · form4-06302021_090602.xml · nonDerivative · entry 11 Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,373 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 19, 2021 Filed Jul 1, 2021 01:45 UTC | NeueHealth, Inc. BHG · Entity 74308 | Exercise / conversionStock Options (Right to Buy) · Derivative | 12,498 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001415889-21-003299 · form4-06302021_090602.xml · derivative · entry 21 Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 437,502 Underlying: Common Stock · 12,498 shares Expires 2030-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These stock options vest over four years as follows: (a) 25% vested on February 19, 2021, and (b) 1/48 of the original grant amount (600,000) vests in monthly installments for the following three years. Read SEC document |
| March 19, 2021 Filed Jul 1, 2021 01:45 UTC | NeueHealth, Inc. BHG · Entity 74308 | GiftCommon Stock | 6,252 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-003299 · form4-06302021_090602.xml · nonDerivative · entry 10 Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · By The Smith Family Grantor Retained Annuity Trust Disclosed balance after: 900,000 F1 · ownership.nature: Each restricted stock unit Catherine R. Smith and Ryan T. Smith are the sole trustees. Read SEC document |
| March 19, 2021 Filed Jul 1, 2021 01:45 UTC | NeueHealth, Inc. BHG · Entity 74308 | GiftCommon Stock | 6,252 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-003299 · form4-06302021_090602.xml · nonDerivative · entry 9 Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,246 Read SEC document |
| March 19, 2021 Filed Jul 1, 2021 01:45 UTC | NeueHealth, Inc. BHG · Entity 74308 | Exercise / conversionCommon Stock | 12,498 | $1.77 | $22,158.95 |
DisclosureSEC source: 0001415889-21-003299 · form4-06302021_090602.xml · nonDerivative · entry 8 Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2021 Filed Jul 1, 2021 01:45 UTC | NeueHealth, Inc. BHG · Entity 74308 | Exercise / conversionStock Options (Right to Buy) · Derivative | 53,124 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001415889-21-003299 · form4-06302021_090602.xml · derivative · entry 20 Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,806,252 Underlying: Common Stock · 53,124 shares Expires 2029-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These stock options vest over four years as follows: (a) 25% vested on January 6, 2021, and (b) 1/48 of the original grant amount (2,550,000) vests in monthly installments for the following three years. Read SEC document |
| March 06, 2021 Filed Jul 1, 2021 01:45 UTC | NeueHealth, Inc. BHG · Entity 74308 | GiftCommon Stock | 53,124 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-003299 · form4-06302021_090602.xml · nonDerivative · entry 7 Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · By The Smith Family Grantor Retained Annuity Trust Disclosed balance after: 893,748 F1 · ownership.nature: Each restricted stock unit Catherine R. Smith and Ryan T. Smith are the sole trustees. Read SEC document |
| March 06, 2021 Filed Jul 1, 2021 01:45 UTC | NeueHealth, Inc. BHG · Entity 74308 | GiftCommon Stock | 53,124 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-003299 · form4-06302021_090602.xml · nonDerivative · entry 6 Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| March 06, 2021 Filed Jul 1, 2021 01:45 UTC | NeueHealth, Inc. BHG · Entity 74308 | Exercise / conversionCommon Stock | 53,124 | $1.77 | $94,188.85 |
DisclosureSEC source: 0001415889-21-003299 · form4-06302021_090602.xml · nonDerivative · entry 5 Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,124 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2021 Filed Jul 1, 2021 01:45 UTC | NeueHealth, Inc. BHG · Entity 74308 | Exercise / conversionStock Options (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001415889-21-003299 · form4-06302021_090602.xml · derivative · entry 19 Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 150,000 shares Expires 2030-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These stock options vest over four years as follows: (a) 25% vested on February 19, 2021, and (b) 1/48 of the original grant amount (600,000) vests in monthly installments for the following three years. Read SEC document |
| February 19, 2021 Filed Jul 1, 2021 01:45 UTC | NeueHealth, Inc. BHG · Entity 74308 | Exercise / conversionStock Options (Right to Buy) · Derivative | 690,624 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001415889-21-003299 · form4-06302021_090602.xml · derivative · entry 18 Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,859,376 Underlying: Common Stock · 690,624 shares Expires 2029-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These stock options vest over four years as follows: (a) 25% vested on January 6, 2021, and (b) 1/48 of the original grant amount (2,550,000) vests in monthly installments for the following three years. Read SEC document |
| February 19, 2021 Filed Jul 1, 2021 01:45 UTC | NeueHealth, Inc. BHG · Entity 74308 | GrantStock Options (Right to Buy) · Derivative | 1,200,000 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001415889-21-003299 · form4-06302021_090602.xml · derivative · entry 17 Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,200,000 Underlying: Common Stock · 1,200,000 shares Expires 2031-02-19 F5 · derivative.exercise_date: These stock options vest over four years as follows: (a) 25% vests on June 24, 2022 and (b) 1/48 of the original grant amount vests in monthly installments for the following three years. Read SEC document |
| February 19, 2021 Filed Jul 1, 2021 01:45 UTC | NeueHealth, Inc. BHG · Entity 74308 | GiftCommon Stock | 840,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-003299 · form4-06302021_090602.xml · nonDerivative · entry 4 Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · By The Smith Family Grantor Retained Annuity Trust Disclosed balance after: 840,624 F1 · ownership.nature: Each restricted stock unit Catherine R. Smith and Ryan T. Smith are the sole trustees. Read SEC document |
| February 19, 2021 Filed Jul 1, 2021 01:45 UTC | NeueHealth, Inc. BHG · Entity 74308 | GiftCommon Stock | 840,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-003299 · form4-06302021_090602.xml · nonDerivative · entry 3 Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 19, 2021 Filed Jul 1, 2021 01:45 UTC | NeueHealth, Inc. BHG · Entity 74308 | Exercise / conversionCommon Stock | 150,000 | $1.77 | $265,950.00 |
DisclosureSEC source: 0001415889-21-003299 · form4-06302021_090602.xml · nonDerivative · entry 2 Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 840,624 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2021 Filed Jul 1, 2021 01:45 UTC | NeueHealth, Inc. BHG · Entity 74308 | Exercise / conversionCommon Stock | 690,624 | $1.77 | $1,224,476.35 |
DisclosureSEC source: 0001415889-21-003299 · form4-06302021_090602.xml · nonDerivative · entry 1 Smith Cathy R · CIK 0001322028 · CFO & ADMINISTRATIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 690,624 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2020 Filed May 7, 2020 20:20 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantStock Option (Right to Buy) · Derivative | 5,293 | $0.00 Strike: $88.74 | $0.00 |
DisclosureSEC source: 0001322028-20-000002 · edgar.xml · derivative · entry 2 Smith Cathy R · CIK 0001322028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,293 Underlying: Common Stock, $1 par value · 5,293 shares Expires 2030-05-03 F2 · derivative.exercise_date: The reporting person received a grant of fully vested Company stock options, subject to the terms and conditions of the applicable grant. Read SEC document |
| May 05, 2020 Filed May 7, 2020 20:20 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 1,099 | $0.00 | $0.00 |
DisclosureSEC source: 0001322028-20-000002 · edgar.xml · nonDerivative · entry 1 Smith Cathy R · CIK 0001322028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,172 F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc. ("Company"), subject to the terms and conditions of the applicable grant. Read SEC document |
| April 16, 2020 Filed Apr 18, 2020 00:23 UTC | PPG INDUSTRIES INC PPG · Entity 3193 | GrantRestricted Stock Units · Derivative | 1,636 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025013 · doc4.xml · derivative · entry 1 Smith Cathy R · CIK 0001322028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,636 Underlying: Common Stock · 1,636 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PPG Common Stock. F2 · derivative.exercise_date: The restricted stock units vest on April 14, 2021. F2 · derivative.expiration_date: The restricted stock units vest on April 14, 2021. Read SEC document |
| April 15, 2020 Filed Apr 18, 2020 00:52 UTC | PPG INDUSTRIES INC PPG · Entity 3193 | Exercise / conversionRestricted Stock Units · Derivative | 1,207 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025014 · doc4.xml · derivative · entry 3 Smith Cathy R · CIK 0001322028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,207 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Upon the vesting of restricted stock units on April 15, 2020, which were granted to the reporting person on April 18, 2019, the reporting person is reporting the acquisition of 1,207 shares of common stock. F1 · derivative.exercise_date: Upon the vesting of restricted stock units on April 15, 2020, which were granted to the reporting person on April 18, 2019, the reporting person is reporting the acquisition of 1,207 shares of common stock. F1 · derivative.expiration_date: Upon the vesting of restricted stock units on April 15, 2020, which were granted to the reporting person on April 18, 2019, the reporting person is reporting the acquisition of 1,207 shares of common stock. Read SEC document |
| April 15, 2020 Filed Apr 18, 2020 00:52 UTC | PPG INDUSTRIES INC PPG · Entity 3193 | Tax withholdingCommon Stock | 4 | $88.48 | $353.92 |
DisclosureSEC source: 0001209191-20-025014 · doc4.xml · nonDerivative · entry 2 Smith Cathy R · CIK 0001322028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,303 Read SEC document |
| April 15, 2020 Filed Apr 18, 2020 00:52 UTC | PPG INDUSTRIES INC PPG · Entity 3193 | Exercise / conversionCommon Stock | 1,207 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025014 · doc4.xml · nonDerivative · entry 1 Smith Cathy R · CIK 0001322028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,307 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Upon the vesting of restricted stock units on April 15, 2020, which were granted to the reporting person on April 18, 2019, the reporting person is reporting the acquisition of 1,207 shares of common stock. Read SEC document |
| August 23, 2019 Filed Aug 26, 2019 23:34 UTC | TARGET CORP TGT · Entity 2967 | SaleCommon Stock | 8,412 | $104.40 | $878,206.91 |
DisclosureSEC source: 0001225208-19-011896 · doc4.xml · nonDerivative · entry 1 Smith Cathy R · CIK 0001322028 · Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,645 F1 · price: Price is the volume weighted average selling price of all sales by the reporting person on the transaction date within a one dollar range. Actual prices ranged from $104.3981 to $104.4110. The reporting person hereby undertakes to provide upon request of the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · balance_after: Includes dividend equivalents paid on performance-based restricted stock units since the date of the reporting person's last filing through the date of the reported transaction that have been reinvested in additional performance-based restricted stock units. Read SEC document |
| May 07, 2019 Filed May 9, 2019 20:12 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantStock Option (Right to Buy) · Derivative | 6,138 | $0.00 Strike: $76.69 | $0.00 |
DisclosureSEC source: 0001322028-19-000001 · edgar.xml · derivative · entry 2 Smith Cathy R · CIK 0001322028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,138 Underlying: Common Stock, $1 par value · 6,138 shares Expires 2029-05-07 F2 · derivative.exercise_date: The reporting person received a grant of fully vested Company stock options, subject to the terms and conditions of the applicable grant. Read SEC document |
| May 07, 2019 Filed May 9, 2019 20:12 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 1,206 | $0.00 | $0.00 |
DisclosureSEC source: 0001322028-19-000001 · edgar.xml · nonDerivative · entry 1 Smith Cathy R · CIK 0001322028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,020 F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc. (the "Company"), subject to the terms and conditions of the applicable grant. Read SEC document |
| April 18, 2019 Filed Apr 22, 2019 18:50 UTC | PPG INDUSTRIES INC PPG · Entity 3193 | GrantRestricted Stock Units · Derivative | 1,207 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-025457 · doc4.xml · derivative · entry 1 Smith Cathy R · CIK 0001322028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,207 Underlying: Common Stock · 1,207 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PPG Common Stock. F2 · derivative.exercise_date: The restricted stock units vest on April 15, 2020. F2 · derivative.expiration_date: The restricted stock units vest on April 15, 2020. Read SEC document |
| April 11, 2019 Filed Apr 12, 2019 14:09 UTC | TARGET CORP TGT · Entity 2967 | SaleCommon Stock | 20,000 | $80.83 | $1,616,594.00 |
DisclosureSEC source: 0001225208-19-006662 · doc4.xml · nonDerivative · entry 1 Smith Cathy R · CIK 0001322028 · Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,883 F1 · price: Price is the volume weighted average selling price of all sales by the reporting person on the transaction date within a one dollar range. Actual prices ranged from $80.585 to $80.99. The reporting person hereby undertakes to provide upon request of the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 09, 2019 Filed Apr 10, 2019 23:42 UTC | TARGET CORP TGT · Entity 2967 | Tax withholdingCommon Stock | 15,905 | $80.88 | $1,286,396.40 |
DisclosureSEC source: 0001225208-19-006640 · doc4.xml · nonDerivative · entry 2 Smith Cathy R · CIK 0001322028 · Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,883 F2 · kind: Withholding of stock to satisfy tax withholding obligation on settlement of performance share unit award referenced in footnote (1). Read SEC document |
| April 09, 2019 Filed Apr 10, 2019 23:42 UTC | TARGET CORP TGT · Entity 2967 | GrantCommon Stock | 34,879 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-006640 · doc4.xml · nonDerivative · entry 1 Smith Cathy R · CIK 0001322028 · Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,788 F1 · kind: Acquired pursuant to the settlement of a performance share unit award granted under the Target Corporation Amended & Restated 2011 Long-Term Incentive Plan. Read SEC document |
| March 12, 2019 Filed Mar 15, 2019 00:34 UTC | TARGET CORP TGT · Entity 2967 | Tax withholdingCommon Stock | 3,854 | $76.14 | $293,443.56 |
DisclosureSEC source: 0001225208-19-005313 · doc4.xml · nonDerivative · entry 2 Smith Cathy R · CIK 0001322028 · Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,909 F3 · kind: Withholding of stock to satisfy tax withholding obligation on vesting of performance-based restricted stock unit award referenced in footnote (1). Read SEC document |
| March 12, 2019 Filed Mar 15, 2019 00:34 UTC | TARGET CORP TGT · Entity 2967 | GrantCommon Stock | 3,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-005313 · doc4.xml · nonDerivative · entry 1 Smith Cathy R · CIK 0001322028 · Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,763 F1 · kind: Acquired pursuant to the settlement of performance-based restricted stock unit award granted under Target's 2011 Long-Term Incentive Plan, including dividend equivalents paid on such shares since the grant date. The award was previously reported by the reporting person on January 15, 2016. F2 · balance_after: Includes dividend equivalents paid on performance-based restricted stock units since the date of the reporting person's last filing through the date of the reported transaction that have been reinvested in additional performance-based restricted stock units. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 22:17 UTC | TARGET CORP TGT · Entity 2967 | SaleCommon Stock | 30,000 | $74.00 | $2,220,000.00 |
DisclosureSEC source: 0001225208-19-004632 · doc4.xml · nonDerivative · entry 1 Smith Cathy R · CIK 0001322028 · Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,334 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan previously entered into by the reporting person on September 20, 2018. F2 · balance_after: Includes dividend equivalents paid on performance-based restricted stock units since the date of the reporting person's last filing through the date of the reported transaction that have been reinvested in additional performance-based restricted stock units. Read SEC document |
| May 08, 2018 Filed May 10, 2018 21:08 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantStock Option (Right to Buy) · Derivative | 6,437 | $0.00 Strike: $69.45 | $0.00 |
DisclosureSEC source: 0001322028-18-000001 · edgar.xml · derivative · entry 2 Smith Cathy R · CIK 0001322028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,437 Underlying: Common Stock, $1 par value · 6,437 shares Expires 2028-05-08 F2 · derivative.exercise_date: The reporting person received a grant of 6,437 fully vested Company stock options, subject to the terms and conditions of the applicable grant. Read SEC document |
| May 08, 2018 Filed May 10, 2018 21:08 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 1,332 | $69.45 | $92,507.40 |
DisclosureSEC source: 0001322028-18-000001 · edgar.xml · nonDerivative · entry 1 Smith Cathy R · CIK 0001322028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,775 F1 · shares: The reporting person received a grant of 1,332 fully vested shares of common stock of Baxter International Inc. (the "Company"), subject to the terms and conditions of the applicable grant. Read SEC document |
| April 09, 2018 Filed Apr 11, 2018 20:47 UTC | TARGET CORP TGT · Entity 2967 | Tax withholdingCommon Stock | 6,512 | $72.07 | $469,319.84 |
DisclosureSEC source: 0001225208-18-007679 · doc4.xml · nonDerivative · entry 2 Smith Cathy R · CIK 0001322028 · Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,544 F2 · kind: Withholding of stock to satisfy tax withholding obligation on settlement of performance share unit award referenced in footnote (1). Read SEC document |
| April 09, 2018 Filed Apr 11, 2018 20:47 UTC | TARGET CORP TGT · Entity 2967 | GrantCommon Stock | 14,279 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-007679 · doc4.xml · nonDerivative · entry 1 Smith Cathy R · CIK 0001322028 · Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,056 F1 · kind: Acquired pursuant to the settlement of a performance share unit award granted under Target's 2011 Long-Term Incentive Plan. Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 21:26 UTC | TARGET CORP TGT · Entity 2967 | GrantCommon Stock | 13,745 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-006325 · doc4.xml · nonDerivative · entry 1 Smith Cathy R · CIK 0001322028 · Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,777 F1 · kind: Award of performance-based restricted stock units pursuant to the Amended and Restated Target Corporation 2011 Long-Term Incentive Plan. Amount reported represents the minimum number of shares that will be delivered upon satisfaction of vesting conditions. Award vests three years after the grant date. Read SEC document |
| March 13, 2018 Filed Mar 16, 2018 00:22 UTC | TARGET CORP TGT · Entity 2967 | Tax withholdingCommon Stock | 1,489 | $71.49 | $106,448.61 |
DisclosureSEC source: 0001225208-18-006261 · doc4.xml · nonDerivative · entry 2 Smith Cathy R · CIK 0001322028 · Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,032 F3 · kind: Withholding of stock to satisfy tax withholding obligation on vesting of performance-based restricted stock unit award referenced in footnote (1). Read SEC document |
| March 13, 2018 Filed Mar 16, 2018 00:22 UTC | TARGET CORP TGT · Entity 2967 | GrantCommon Stock | 1,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-006261 · doc4.xml · nonDerivative · entry 1 Smith Cathy R · CIK 0001322028 · Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,521 F1 · kind: Acquired pursuant to the settlement of performance-based restricted stock unit award granted under Target's 2011 Long-Term Incentive Plan, including dividend equivalents paid on such shares since the grant date. The award was previously reported by the reporting person on September 3, 2015. F2 · balance_after: Includes dividend equivalents paid on performance-based restricted stock units since the date of the reporting person's last filing through the date of the reported transaction that have been reinvested in additional performance-based restricted stock units. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 20:13 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 2,425 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001322028-17-000004 · edgar.xml · nonDerivative · entry 1 Smith Cathy R · CIK 0001322028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,425 F1 · price: The reporting person received a grant of 2,425 fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the grant. Read SEC document |
| May 22, 2017 Filed May 24, 2017 23:44 UTC | TARGET CORP TGT · Entity 2967 | GrantStock Option · Derivative | 147,276 | $0.00 Strike: $55.60 | $0.00 |
DisclosureSEC source: 0001225208-17-010393 · doc4.xml · derivative · entry 2 Smith Cathy R · CIK 0001322028 · Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,276 Underlying: Common Stock · 147,276 shares Expires 2024-05-22 F2 · security: An award of price-vested stock options under the Amended and Restated Target Corporation 2011 Long-Term Incentive Plan. F3 · derivative.exercise_date: In addition, the price-vested stock options will become exercisable only if the closing price of Target's stock exceeds a hurdle of $75 for 20 consecutive trading days within the seven-year term. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 01:28 UTC | TARGET CORP TGT · Entity 2967 | Tax withholdingCommon Stock | 4,826 | $55.28 | $266,781.28 |
DisclosureSEC source: 0001225208-17-006031 · doc4.xml · nonDerivative · entry 2 Smith Cathy R · CIK 0001322028 · Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,223 F2 · kind: Withholding of stock to satisfy tax withholding obligation on settlement of performance share unit award referenced in footnote (1). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.